Startups
TOLREMO therapeutics
https://tolremo.comDeveloper of small molecules to treat novel drug resistance pathways in cancer therapy.
Summary
Industry
Total funding Amount
$37M
Fundraising History
-
Sep 20 '23 Series A$20M
-
Jun 20 '20 Series A$5.1M
-
Sep 24 '18 Series A$9.9M
-
Sep 19 '17 Seed$2.6M
Investors
-
Series A
-
Series A
-
Series A